发明名称 Viral polymerase inhibitors
摘要 An isomer, enantiomer, diastereoisomer, or tautomer of a compound, represented by formula I: wherein: A is O, S, NR1, or CR1, wherein R1 is defined herein; — represents either a single or a double bond; R2 is selected from: H, halogen, R21, OR21, SR21, COOR21, SO2N(R22)2, N(R22)2, CON(R22)2, NR22C(O)R22 or NR22C(O)NR22 wherein R21 and each R22 is defined herein; B is NR3 or CR3, with the proviso that one of A or B is either CR1 or CR3, wherein R3 is defined herein; K is N or CR4, wherein R4 is defined herein; L is N or CR5 wherein R5 has the same definition as R4 defined above; M is N or CR7, wherein R7 has the same definition as R4 defined above; Y1 is O or S; Z is N(R6a)R6 or OR6, wherein R6a is H or alkyl or NR61R62 wherein R61 and R62 are defined herein; a salt or a derivative thereof, as an inhibitor of HCV NS5B polymerase.
申请公布号 US7803944(B2) 申请公布日期 2010.09.28
申请号 US20060464651 申请日期 2006.08.15
申请人 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 发明人 BEAULIEU PIERRE LOUIS;FAZAL GULREZ;KUKOLJ GEORGE;JOLICOEUR ERIC;GILLARD JAMES;POUPART MARC-ANDRE;RANCOURT JEAN
分类号 C07D471/04;A61K31/12;A61K31/13;A61K31/381;A61K31/404;A61K31/405;A61K31/407;A61K31/4184;A61K31/422;A61K31/427;A61K31/428;A61K31/4353;A61K31/437;A61K31/443;A61K31/4436;A61K31/4439;A61K31/454;A61K31/4545;A61K31/4709;A61K31/497;A61K31/506;A61K31/53;A61K31/5377;A61K31/7052;A61K38/21;A61K45/00;A61P31/12;A61P31/14;A61P37/02;A61P43/00;C07D209/08;C07D209/14;C07D209/20;C07D209/30;C07D209/42;C07D333/62;C07D401/04;C07D401/06;C07D401/12;C07D401/14;C07D403/04;C07D405/04;C07D405/12;C07D405/14;C07D407/14;C07D409/04;C07D409/14;C07D413/04;C07D413/14;C07D417/04;C07D417/12;C07D417/14;C07D471/02;C07D487/04;C07D491/02;C07D498/02;C07H19/056 主分类号 C07D471/04
代理机构 代理人
主权项
地址